Leading Specialty Pharma Co Selects MC3’s Tabletop® Learning Platform

Today, MC3 announced an important new enterprise license agreement with the specialty division of a top 10 pharmaceutical company. The one year agreement provides the client with unlimited access to MC3’s Tabletop® technology, for the specific purpose of establishing a dynamic learning platform that will house, distribute and track user specific content to support the training and ongoing development of the sales organization. This client has previously utilized Tabletop® to support launch and sales meetings and is expanding its use of the platform through this enterprise agreement.

Robert Armstrong, MC3 President and operating partner commented: “We are delighted that this long term Tabletop® client has chosen to expand its use of the platform. Over the years, they have successfully leveraged Tabletop® to create highly engaging meetings and events based training and are now expanding the technology’s utility to create a year round learning platform that will meet their broader training objectives. By licensing the platform they realize continuous benefits at a more efficient price point. This is the kind of win-win that we seek to establish with all of our clients.”

About Tabletop®: Tabletop® is MC3’s proprietary Saas based meeting, training and field force engagement platform that was developed specifically for the life sciences industry. It is offered to clients on a single event basis or can be licensed on an annual or multiyear basis. Clients have the option to manage the administration of the platform themselves, engage MC3 to provide platform administration service and support or a combination of both.